logo

OARSI 2016

April 01, 2016


Welcome and introduction

Osteoarthritis Progression and Biomarkers: Introduction
MARC C. HOCHBERG, MD, MPH


Osteoarthritis biomarkers: what's on the horizon?
ALI MOBASHERI, DPhil (Oxon.)


Biomarkers as drug development tools: from clinical outcome to therapeutic target
YVES HENROTIN, PT, MT, PhD


Predictive Biomarkers of Therapeutic Response in Osteoarthritis
FRANCISCO J. BLANCO, MD, PhD


24 Month study on structural changes in knee osteoarthritis assessed by MRI with Chondroitin sulfate
JEAN-PIERRE PELLETIER


Can we objectively measure the efficacy of treatments? usefulness of bone morphology changes
JOHANNE MARTEL-PELLETIER, PhD


Question and answer session


Any doubt?
Contact us and we will write
you as soon as posible.

Contact